Elekta AB stock (SE0000163628): Shares rise as short interest update lands

Elekta shares traded higher in Stockholm on 06/03/2026, while a fresh market short-position update kept the Swedish medtech name in focus.

Elekta shares were trading higher in Stockholm on 06/03/2026, with the Swedish-listed medtech group also showing a smaller but notable move in Frankfurt-traded lines during the same session, according to market data and a Stockholm short-position update dated 06/02/2026.

The stock traded at 57.80 SEK on 06/03/2026 on Nasdaq Stockholm, according to Finanzen.net as of 06/03/2026. In Germany, the stock was quoted at 5.29 EUR on Tradegate on 06/03/2026, which gives German investors a local-currency reference point for the same Swedish listing.

As of: 06/03/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: Elekta
• Sector/industry: Medical technology, radiation therapy systems
• Headquarters/country: Stockholm, Sweden
• Core markets: Europe, North America, Asia-Pacific
• Key revenue drivers: Linear accelerators, treatment planning software, service and support
• Home exchange/listing venue: Nasdaq Stockholm (EKTA B)
• Trading currency: SEK

Elekta AB: core business model

Elekta builds and services radiation oncology systems used by hospitals and cancer centers, with recurring income supported by software, maintenance, and upgrades rather than one-off equipment sales alone.

Elekta AB in peer comparison

In Sweden, Elekta's latest visible market catalyst came alongside an aggregate short-position update for the Stockholm exchange dated 06/02/2026, which listed Elekta among names with notable reported short interest changes.

Japan remains an important commercial market for the group, and Elekta K.K. was highlighted in a 06/02/2026 feature on cancer-treatment technology in Japan, underlining the company's exposure to one of the most developed radiotherapy markets in Asia.

That matters because Elekta competes in a capital-intensive field where purchasing cycles are long, service relationships are sticky, and installed base economics can matter as much as new system wins. A current market read-through can therefore come from both trading data and operating coverage, not just earnings day headlines.

Conclusion

For Swedish investors, the immediate story is the modestly firmer share price in Stockholm and the fresh short-position data point that keeps Elekta in focus on Nasdaq Stockholm.

With Wednesday's peer-comparison lens, the stock is best read through its competitive position in radiotherapy rather than through a single day's move alone.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.